151 – 160 of 249
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Huntington's disease: a synaptopathy?
- Contribution to journal › Article
-
Mark
Grafting dopamine neurons in Parkinson's disease: do stem cells have a role in the future?
- Contribution to journal › Article
-
Mark
Fria radikaler och sjuka proteiner - bovarna bakom Parkinsons sjukdom?[Free radicals and ailing proteins - the culprits behind Parkinson’s disease?]
- Contribution to journal › Article
- 2002
-
Mark
GDNF treatment in Parkinson's disease: time for controlled clinical trials?
- Contribution to journal › Letter
-
Mark
Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease
- Contribution to journal › Article
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
- Contribution to journal › Article
-
Mark
Characterisation of cell damage and death in embryonic mesencephalic tissue: a study on ultrastructure, vital stains and protease activity.
- Contribution to journal › Article
-
Mark
Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
- Contribution to journal › Article
-
Mark
Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease.
- Contribution to journal › Article
-
Mark
Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.
- Contribution to journal › Scientific review
